These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 15534162

  • 41. B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient.
    Maisel A.
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S10-7. PubMed ID: 12439426
    [Abstract] [Full Text] [Related]

  • 42. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 43. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB.
    Am J Cardiol; 2005 Apr 15; 95(8):948-54. PubMed ID: 15820160
    [Abstract] [Full Text] [Related]

  • 44. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Hoes AW, van Veldhuisen DJ.
    Am Heart J; 2006 May 15; 151(5):1012.e1-5. PubMed ID: 16644323
    [Abstract] [Full Text] [Related]

  • 45. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G.
    Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415
    [Abstract] [Full Text] [Related]

  • 46. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure.
    Aspromonte N, Feola M, Milli M, Scardovi AB, Coletta C, Carbonieri E, Giovinazzo P, Di Giacomo T, Barro S, Rosso GL, Ceci V, Milani L, Valle R.
    Diabet Med; 2007 Feb 14; 24(2):124-30. PubMed ID: 17257273
    [Abstract] [Full Text] [Related]

  • 47. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L.
    J Cardiovasc Med (Hagerstown); 2009 Sep 14; 10(9):671-6. PubMed ID: 19444135
    [Abstract] [Full Text] [Related]

  • 48. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 14; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 49. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
    Christ M, Laule-Kilian K, Hochholzer W, Klima T, Breidthardt T, Perruchoud AP, Mueller C.
    J Am Coll Cardiol; 2006 Nov 07; 48(9):1808-12. PubMed ID: 17084254
    [Abstract] [Full Text] [Related]

  • 50. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
    Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Gonçalves F, Bettencourt P.
    Liver Int; 2010 Aug 07; 30(7):1059-66. PubMed ID: 20492497
    [Abstract] [Full Text] [Related]

  • 51. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
    Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH, de Lemos JA.
    Circulation; 2005 Oct 04; 112(14):2163-8. PubMed ID: 16203929
    [Abstract] [Full Text] [Related]

  • 52. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 53. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.
    Circulation; 2005 Sep 20; 112(12):1756-62. PubMed ID: 16157772
    [Abstract] [Full Text] [Related]

  • 54. Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice.
    Mair J, Gerda F, Renate H, Ulmer H, Andrea G, Pachinger O.
    Int J Cardiol; 2008 Feb 29; 124(2):244-6. PubMed ID: 17360054
    [Abstract] [Full Text] [Related]

  • 55. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].
    Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H.
    Ann Biol Clin (Paris); 2005 Feb 29; 63(1):43-9. PubMed ID: 15689311
    [Abstract] [Full Text] [Related]

  • 56. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.
    J Card Fail; 2008 Apr 29; 14(3):219-24. PubMed ID: 18381185
    [Abstract] [Full Text] [Related]

  • 57. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):205-14. PubMed ID: 17631211
    [Abstract] [Full Text] [Related]

  • 58. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
    Ralli S, Horwich TB, Fonarow GC.
    Am Heart J; 2005 Dec 17; 150(6):1220-7. PubMed ID: 16338262
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
    Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M.
    Clin Chim Acta; 2006 Aug 17; 370(1-2):174-9. PubMed ID: 16600203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.